ILK is a critical regulator of the cancer-survival pathway, including PI3K/AKT, glycogen synthase kinase 3β (GSK3β), nuclear factor-kappaβ (NF-κβ), mTOR, or Snail1/E-cadherin/N-cadherin [20,22,23]. Here, AKT1 is linked to cancer.